Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Medical Genetics · Hepatic Lipase Deficiency

Understanding Hepatic Lipase Deficiency

At a Glance

Hepatic lipase deficiency is a rare inherited LIPC-related disorder that changes how the body remodels blood fats. Lipid levels vary widely; very high triglycerides can rarely cause pancreatitis, so care focuses on individualized risk assessment, lifestyle, and monitoring.

Receiving a diagnosis of hepatic lipase deficiency (also known as hepatic triacylglycerol lipase deficiency) can be a disorienting experience. This is a very rare condition, with a limited number of well-characterized families reported in medical literature [1][2]. Because it is so uncommon, even many experienced doctors may never have encountered a case. It is natural to feel a sense of isolation or anxiety when the “road map” for your condition is still being written by researchers.

Understanding the biology of this condition can help you navigate your care and have more productive conversations with your medical team.

What is Hepatic Lipase Deficiency?

This condition is a rare genetic disorder that affects how your body processes fats (lipids) in the bloodstream. Specifically, your body has difficulty producing or using an enzyme called hepatic lipase [1].

To understand the deficiency, it helps to know what the enzyme normally does:

  • The Remodeling Tool: Think of hepatic lipase as a specialized tool the liver uses to “trim” and reshape fat particles in the blood. It primarily helps remodel IDL, HDL, and remnant particles [3][1].
  • Triglycerides and Phospholipids: These are fats carried inside your lipoprotein particles. The enzyme works to break down these fats [4].
  • HDL and LDL Management: It converts larger, less-dense particles into smaller, more-dense versions. In a typical person, this process helps maintain a healthy balance of different lipid types [5][6].

When this enzyme is missing or doesn’t work correctly, these fat particles aren’t “trimmed” or cleared as they should be. This leads to an unusual buildup of certain lipids and a change in the physical structure of your cholesterol particles [5].

The Role of the LIPC Gene

The instructions for building the hepatic lipase enzyme are carried in a specific gene called LIPC. In your case, the diagnosis means there are changes (variants) in this gene that prevent it from providing the correct instructions to the liver [2].

This condition is inherited in an autosomal recessive pattern. This means:

  1. You inherited one non-working copy of the LIPC gene from your mother and one from your father [2].
  2. Your parents are likely “carriers”—they usually have one working gene and one non-working gene. Carriers typically do not have the full deficiency, though some recent research suggests they might have measurable differences in their lipid levels compared to people with two working genes [7].

A Note on Genetic Results: A genetic variant is different from a confirmed disease. Variants known to cause disease are labeled “pathogenic” or “likely pathogenic,” whereas a “Variant of Uncertain Significance” (VUS) means the lab isn’t sure. Relatives should receive genetic counseling before testing.

Why It Looks Different for Everyone

In the medical world, the way a disease shows up in a person is called their phenotype. One of the most challenging aspects of hepatic lipase deficiency is that the phenotype is highly variable [2]. This means that two people with the same genetic diagnosis might have very different blood test results.

Some people with this deficiency have:

  • Moderate elevations in triglycerides and modest increases in both LDL-C and HDL-C [5].
  • Varying particle sizes: A distinctive feature of this condition is often an unusual distribution of HDL particle sizes (some are much larger than normal, while others are unusually small) [5].
  • Rare, severe symptoms: In rare instances, very high triglyceride levels can lead to complications like pancreatitis (inflammation of the pancreas), though this is not common for everyone with the condition [2].

This variability happens because other factors influence how your body handles fats. These include your other genes, your diet, your weight, your sex, and whether you have other health conditions like diabetes [4][8]. Because the condition is so rare, there isn’t a “standard” lipid profile that applies to everyone; your treatment will likely be tailored specifically to your individual numbers and health history.

What is Known and What Remains Uncertain

While we know that complete hepatic lipase deficiency causes abnormal lipid profiles and high triglycerides carry a risk of pancreatitis, the exact long-term cardiovascular risks are not perfectly quantified for this specific rare disorder. Risk cannot be predicted from the gene result alone. Because there are no specific national guidelines just for hepatic lipase deficiency, your doctor will likely use general lipid-management strategies to keep you healthy. This often involves a focus on heart-healthy lifestyle choices—such as a low-fat diet and regular physical activity—to help your body manage the lipids that the hepatic lipase enzyme cannot [9].

While the rarity of this condition can be overwhelming, it also means your care is highly individualized. Working with a specialist (like a lipidologist or a geneticist) can help ensure that your specific version of this condition is monitored closely over time based on conventional risks [10].

Common questions in this guide

What is hepatic lipase deficiency?
Hepatic lipase deficiency is a rare inherited disorder that affects an enzyme made by the liver. Without enough working enzyme, the body handles blood-fat particles differently, which can lead to variable triglyceride and cholesterol results.
How is hepatic lipase deficiency inherited?
The condition usually follows an autosomal recessive pattern, meaning a person inherits a non-working LIPC gene copy from each parent. Parents with one non-working copy are usually carriers and do not have the full deficiency; genetic counseling can help relatives understand testing options.
What might a lipid panel show with hepatic lipase deficiency?
Results can vary substantially between people. Testing may show moderate triglyceride elevation, modest increases in LDL and HDL cholesterol, and an unusual mix of larger and smaller HDL particles, so there is no single typical lipid pattern.
Can hepatic lipase deficiency cause pancreatitis or heart disease?
Very high triglyceride levels can rarely contribute to pancreatitis, an inflammation of the pancreas. The long-term cardiovascular risk specific to hepatic lipase deficiency is not fully established, so clinicians assess the person's lipid results and other conventional risk factors.
How is hepatic lipase deficiency managed?
There are no specific national guidelines for this rare disorder, so care is individualized using general lipid-management strategies. A heart-healthy low-fat diet, regular physical activity, and monitoring based on lipid levels and other risk factors may be recommended.
What does a variant of uncertain significance in LIPC mean?
A variant of uncertain significance means the laboratory does not yet know whether the genetic change causes disease. It should not be treated as confirmation by itself, and a genetic counselor or genetics professional can explain what the result means for the patient and family.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Hyperlipidemia due to hepatic triacylglycerol lipase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are the specific variants found in my LIPC gene, and have they been confirmed to be 'pathogenic' or 'likely pathogenic'?
  2. 2.Was my testing able to look for large deletions in the gene, or just small spelling changes?
  3. 3.How do my current lipid levels compare to the typical patterns seen in other people with hepatic lipase deficiency?
  4. 4.Should I be referred to a specialized lipid clinic or a genetic counselor to discuss the long-term implications of this rarity?
  5. 5.Given how rare this is, what specific monitoring do you recommend based on my conventional risk factors?

References

References (10)
  1. 1

    Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.

    Kobayashi J, Miyashita K, Nakajima K, Mabuchi H

    Journal of atherosclerosis and thrombosis 2015; (22(10)):1001-11 doi:10.5551/jat.31617.

    PMID: 26194979
  2. 2

    Hypertriglyceridemia Induced Acute Pancreatitis Caused by a Novel LIPC Gene Variant in a Pediatric Patient.

    Balanescu L, Cardoneanu A, Stanciu G, et al.

    Children (Basel, Switzerland) 2022; (9(2)) doi:10.3390/children9020188.

    PMID: 35204909
  3. 3

    Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

    Yang P, Subbaiah PV

    Biochimica et biophysica acta 2015; (1851(10)):1327-36.

    PMID: 26193433
  4. 4

    Pleiotropic association of LIPC variants with lipid and urinary 8-hydroxy deoxyguanosine levels in a Taiwanese population.

    Teng MS, Wu S, Hsu LA, et al.

    Lipids in health and disease 2019; (18(1)):111 doi:10.1186/s12944-019-1057-9.

    PMID: 31077211
  5. 5

    High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.

    Tani M, Horvath KV, Lamarche B, et al.

    Atherosclerosis 2016; (253()):7-14 doi:10.1016/j.atherosclerosis.2016.08.014.

    PMID: 27573733
  6. 6

    2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.

    Goldberg IJ

    Arteriosclerosis, thrombosis, and vascular biology 2018; (38(4)):700-706 doi:10.1161/ATVBAHA.117.309666.

    PMID: 29419410
  7. 7

    Phenotype in Individuals with Heterozygous Rare Variants in LIPC Encoding Hepatic Lipase.

    Jacob EO, Wang J, McIntyre AD, Hegele RA

    International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111445.

    PMID: 39518997
  8. 8

    Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.

    Andrés-Blasco I, Herrero-Cervera A, Vinué Á, et al.

    The Journal of endocrinology 2015; (227(3)):179-91 doi:10.1530/JOE-15-0219.

    PMID: 26423094
  9. 9

    Primary hypertriglyceridemia in children and adolescents.

    Shah AS, Wilson DP

    Journal of clinical lipidology 2015; (9(5 Suppl)):S20-8.

    PMID: 26343209
  10. 10

    Can genetic testing help in the management of dyslipidaemias?

    Lazarte J, Hegele RA

    Current opinion in lipidology 2020; (31(4)):187-193 doi:10.1097/MOL.0000000000000690.

    PMID: 32520779

This page explains hepatic lipase deficiency, LIPC inheritance, and lipid monitoring for informational purposes only; it does not constitute medical advice. Discuss genetic results, cardiovascular risk, and possible pancreatitis symptoms with your healthcare team.